Unresectable Chondrosarcomas Treated With Carbon Ion Radiotherapy: Relationship Between Dose-averaged Linear Energy Transfer and Local Recurrence

Background/Aim: The local control rate of chondrosarcomas treated with carbon-ion radiotherapy (CIRT) worsens as tumour size increases, possibly because of the intra-tumoural linear energy transfer (LET) distribution. This study aimed to evaluate the relationship between local recurrence and intra-t...

Full description

Saved in:
Bibliographic Details
Published inAnticancer research Vol. 40; no. 11; pp. 6429 - 6435
Main Authors MATSUMOTO, SHINNOSUKE, LEE, SUNG HYUN, IMAI, REIKO, INANIWA, TAKU, MATSUFUJI, NARUHIRO, FUKAHORI, MAI, KOHNO, RYOSUKE, YONAI, SHUNSUKE, OKONOGI, NORIYUKI, YAMADA, SHIGERU, KANEMATSU, NOBUYUKI
Format Journal Article
LanguageEnglish
Published Athens International Institute of Anticancer Research 01.11.2020
Subjects
Online AccessGet full text
ISSN0250-7005
1791-7530
1791-7530
DOI10.21873/anticanres.14664

Cover

More Information
Summary:Background/Aim: The local control rate of chondrosarcomas treated with carbon-ion radiotherapy (CIRT) worsens as tumour size increases, possibly because of the intra-tumoural linear energy transfer (LET) distribution. This study aimed to evaluate the relationship between local recurrence and intra-tumoural LET distribution in chondrosarcomas treated with CIRT. Patients and Methods: Thirty patients treated with CIRT for grade 2 chondrosarcoma were included. Dose-averaged LET (LETd) distribution was calculated by the treatment planning system, and the relationship between LETd distribution in the planning tumour volume (PTV) and local control was evaluated. Results: The mean LETd value in PTV was similar between cases with and without recurrence. Recurrence was not observed in cases where the effective minimum LETd value exceeded 40 keV/μm. Conclusion: LETd distribution in PTV is associated with local control in chondrosarcomas and patients treated with ion beams of higher LETd may have an improved local control rate for unresectable chondrosarcomas.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0250-7005
1791-7530
1791-7530
DOI:10.21873/anticanres.14664